Institutionelle bei Immunex

Im Folgenden steht an erster Stelle der Name des institutionellen Shareholders bzw. Fonds, an zweiter Stelle die Anzahl der gehaltenen Aktien und an dritter Stelle der Wert des gehaltenen Aktienpakets.

Institutionelle Shareholder
Wellington Management Company 23,191,542 $518,099,048
Barclays Bank Plc 15,937,537 $356,044,576
Vanguard Group, Inc. (The) 9,837,819 $219,776,876
Taunus Corporation 7,783,566 $173,884,864
JP Morgan Chase & Company 7,568,900 $169,089,226
Orbimed Advisors Inc. 6,344,800 $141,742,832
Alger (Fred) Management Inc 5,483,810 $122,508,315
Brinson Partners, Inc. 5,432,901 $121,371,008
Morgan Stanley 5,264,637 $117,611,990
Zurich Scudder Investments, Inc. 4,350,090 $97,181,010

Topliste der investierten Fonds
Homestead Funds Inc-Nasdaq 100 Index Tracking Stock Fund 14,636,734 $326,984,637
Vanguard Specialized-Health Care Fund 11,988,700 $267,827,558
Fidelity Growth Company Fund 7,609,800 $170,002,932
Fidelity Aggressive Growth Fund 7,298,700 $163,052,958
Fidelity Independence Fund 7,182,500 $160,457,050
Vanguard Index 500 Fund 4,502,981 $100,596,595
Merrill Lynch Fundamental Growth Fund 3,665,000 $81,876,100
Fidelity Select Portfolios - Biotechnology 3,647,740 $81,490,511
Eaton Vance Global Health Portfolio 3,200,000 $71,488,000
Vanguard Institutional Index Fund 1,822,156 $40,706,965